All patients (N = 708) | Patients with > 1 substance use measurement (N = 171) | |
---|---|---|
Age (years), n (%) | ||
18–30 | 84 (12) | 11 (6) |
30–40 | 204 (29) | 43 (25) |
40–50 | 215 (30) | 57 (33) |
50–60 | 164 (23) | 47 (27) |
≥ 60 | 41 (6) | 13 (8) |
Mean (SD) | 43 (11) | 46 (10) |
Gender, n (%) | ||
Male | 514 (73) | 130 (76) |
Female | 194 (27) | 41 (24) |
Highest education level, n (%) | ||
Not completed primary school | 39 (6) | 11 (6) |
Completed primary school (9 years) | 306 (44) | 77 (45) |
Completed high school (12 years) | 277 (40) | 66 (39) |
≤ 3 years of college or university | 58 (8) | < 15 (< 10) |
> 3 years of college or university | 14 (2) | < 15 (< 10) |
Injected substances during the past 6 months, n (%) | 384 (54) | 82 (48) |
Unstable housing situation during the past 30 daysa, n (%) | 86 (12) | 5 (4) |
Substance use during the past 12 monthsb, n (%) | ||
Alcohol | 513 (72) | 113 (66) |
Benzodiazepines | 489 (69) | 126 (74) |
Cannabis | 537 (76) | 133 (78) |
Opioids | 344 (49) | 75 (44) |
Stimulants (amphetamines and cocaine) | 451 (64) | 103 (60) |
Inpatient detoxification, n (%) | – | 35 (20) |
Received OAT, n (%) | 553 (78) | 166 (97) |
Received municipality care, n (%) | 155 (22) | 5 (3) |
Comorbidities, n (%) | ||
Hepatitis C virus infection | 349 (60) | 89 (57) |
Hepatitis B virus infection | 5 (< 1) | < 5 (< 5) |
Human immunodeficiency virus infection | < 5 (< 5) | < 5 (< 5) |